Literature DB >> 16736428

The pathology of jaundice-related renal insufficiency: cholemic nephrosis revisited.

Michiel G H Betjes1, Ingeborg Bajema.   

Abstract

The spectrum of jaundice-related nephropathy can range from limited proximal tubulopathy to renal failure. The latter condition was known as cholemic nephrosis in the early literature on this subject. Elevated plasma concentrations of bile salts and bilirubin conjugated or not, putatively mediate the nephrotoxicity. A functional derangement of renal tubule cells is considered to underlie the nephropathy, but published data on renal histology are scarce. In this report, we describe the renal biopsies of two jaundiced patients with reduced creatinine clearance, and we critically review the literature on the pathogenesis of jaundice-related nephropathy. Normal renal architecture, indicating functional renal impairment, and extensive renal tubule necrosis were both observed in jaundice-related renal failure. The findings fit the original description of cholemic nephrosis. Both bilirubin and bile salts are potential nephrotoxins in animal models, but their precise role in the pathogenesis of jaundice-related nephropathy is not known. Patients with bilirubin plasma concentrations >20 mg/dL, a low serum albumin concentration or endo-toxemia, could be more prone to develop renal failure due to jaundice-related tubulopathy. In conclusion, jaundice-related nephropathy is essentially a tubulopathy, but the exact nature of the Pathogenesis is still uncertain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736428

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  26 in total

1.  Severe cholestatic hyperbilirubinaemia secondary to thyrotoxicosis complicated with bile cast nephropathy treated with plasma exchange and haemodialysis.

Authors:  Anthony J Ocon; Matthew Rosenblum; James Desemone; Richard Blinkhorn
Journal:  BMJ Case Rep       Date:  2019-06-05

2.  Cholemic nephrosis (bile cast nephropathy) with severe liver dysfunction.

Authors:  Tanushri Mukherjee; Inam Danish Khan; Rena Guha; Tanmay Ganguly
Journal:  Med J Armed Forces India       Date:  2018-10-11

Review 3.  Acute kidney injury in acute on chronic liver failure.

Authors:  Rakhi Maiwall; S K Sarin; Richard Moreau
Journal:  Hepatol Int       Date:  2015-10-15       Impact factor: 6.047

4.  Cholemic or Bile Cast Nephropathy in a Child with Liver Failure.

Authors:  Vikrant Sood; Bikrant B Lal; Suman Lata; Archana Rastogi; Seema Alam
Journal:  J Clin Exp Hepatol       Date:  2017-05-15

Review 5.  Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis.

Authors:  Juan Carlos Q Velez; George Therapondos; Luis A Juncos
Journal:  Nat Rev Nephrol       Date:  2019-11-13       Impact factor: 28.314

6.  Efficacy of extracorporeal albumin dialysis for acute kidney injury due to cholestatic jaundice nephrotoxicity.

Authors:  Florence Sens; Justine Bacchetta; Maud Rabeyrin; Laurent Juillard
Journal:  BMJ Case Rep       Date:  2016-07-07

Review 7.  Bile cast nephropathy: A case report and review of the literature.

Authors:  Jaymon Patel; Saqib Walayat; Nikhil Kalva; Sidney Palmer-Hill; Sonu Dhillon
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

8.  Cholemic Nephrosis from Acute Hepatitis E Virus Infection: A Forgotten Entity?

Authors:  S Nayak; M Sharma; A Kataria; S C Tiwari; A Rastogi; A Mukund
Journal:  Indian J Nephrol       Date:  2018 May-Jun

9.  Jaundice-associated acute kidney injury.

Authors:  Jie Song; Anthony Chang
Journal:  NDT Plus       Date:  2008-09-11

10.  Clinical outcomes and healthcare utilization of acute hepatitis A virus infection with acute kidney injury in hospitalized patients.

Authors:  Ahmad Khan; Khadija Sami; Adnan Malik; Muhammad Mujtaba Bhinder; Khadija Naseem; Kamesh Gupta; Arsalan Siddiqui; Emad Mansoor; Shailendra Singh; Khalid Mumtaz
Journal:  Eur J Gastroenterol Hepatol       Date:  2021-12-01       Impact factor: 2.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.